China Pharmaceutical Packaging Market Key Players Becton, Dickinson and Company, Gerresheimer AG, SCHOTT AG, Shandong Pharmaceutical Glass Co., Ltd., Hongguang Medicine Packaging Company and Others

Being incentivized by the burgeoning pharmaceuticals industry, Chinese pharmaceutical packaging market size sustained growth rates of around 10% in recent years, and outstripped RMB100 billion in 2018, up to RMB107.4 billion, and it will be at least RMB200 billion in 2025 under the impetus of population aging, two-child policy, the boom of biological agents and related favorable policies.

Get Discount on this Research Report at https://www.reportsnreports.com/contacts/discount.aspx?name=2240621

In China, the high-end pharmaceutical packaging market is currently carved up by multinational corporations, typically BD, Gerresheimer, SCHOTT, Nipro and Amcor; Chinese companies just focus on low- and mid-end markets, but they tend to move toward the high-end by lavishing more on research and development as pharmaceutical packaging standards grow stricter.
A total of over 1,500 Chinese pharmaceutical packaging companies fall into three kinds: a handful of pharmaceutical giants that concentrate on independent production, like Sichuan Kelun Pharmaceutical Co., Ltd.; players which not only work on pharmaceutical packaging but have offerings for food, healthcare products and consumer goods packaging, such as Shandong Linuo Technical Glass Co., Ltd., Heilongjiang Tongyu Pharmaceutical Packaging Co., Ltd. and Shanghai Haishun New Pharmaceutical Packaging Co., Ltd.; and those committing themselves to the R&D, production and sales of pharmaceutical packaging materials, for instance, Shandong Pharmaceutical Glass Co., Ltd., Guizhou Chienyeh Pharmaceutical Packaging Co., Ltd., Shanxi Hongguang Medicine Packaging Co., Ltd. and Hebei First Rubbebr Medical Technology Co., Ltd.. In the lowly concentrated pharmaceutical packaging market of China, even the pharmaceutical glass bellwether Shandong Pharmaceutical Glass Co., Ltd. takes a tiny share of 2.4% in 2018.

For More Details Inquire at https://www.reportsnreports.com/contacts/inquirybeforebuy.aspx?name=2240621

China’s pharmaceutical packaging industry holds the following trends:
1. New types of pharmaceutical packaging materials emerge.
China has built a standard system for pharmaceuticals industry over the years. The country pays more and more attention to the stability of pharmaceutical packaging materials during the drug storage period, and safety when used. Under this background, new types of green, degradable and easy-to-use pharmaceutical packaging materials and vessels are in the palmy days.

2. The industry is becoming more concentrated.
Mergers and acquisitions among pharmaceutical packaging companies occurred frequently in recent years, thanks to favorable policies like the Guidance on Accelerating the Merger and Reorganization of Enterprises in Key Industries. For instance, Shandong Pharmaceutical Glass Co., Ltd. acquired Sichuan Mianzhu Chengxin Pharmaceutical Glass Co. Ltd.; Anhui BBCA Pharmaceutical Co., Ltd. acquired Chengdu PUSH Pharmaceutical Co., Ltd.; China Jianyin Investment Ltd. (JIC) acquired SGD Pharma; and Guizhou Chienyeh Pharmaceutical Packaging Co., Ltd. acquired Nanchong Sanying Medicinal Packaging Material Co., Ltd., Accordingly, Chinese pharmaceutical packaging market is increasingly concentrated.

3. Neutral borosilicate products substitute for low borosilicate products.
As people lead a better life, they require better quality of pharmaceutical packaging materials. A growing number of companies have applied international standard-based neutral borosilicate glass. Several companies including Shandong Pharmaceutical Glass Co., Ltd., Chongqing Zhengchuan Glass Co., Ltd., Cangzhou Four Stars Glass Co., Ltd., Anhui Huaxin Medicinal Glass Products Co., Ltd., Baoji Tongli Pharmaceutical Glass Co., Ltd. and Ningbo Zhengli Pharmaceutical Packing Co., Ltd. have been approved to roll out their neutral borosilicate glass products. Driven by companies that have passed consistency evaluation, neutral borosilicate products will become an alternative to low borosilicate products in China. The injection packaging materials field alone will see RMB3 billion to RMB9 billion be replaced.

Direct Purchase of this Research Report at https://www.reportsnreports.com/purchase.aspx?name=2240621

China Pharmaceutical Packaging Industry Report, 2019-2025 highlights the following:
• China pharmaceutical packaging industry (development status, market size, competitive pattern, import & export, market segments, downstream demand, and development trend);
• 4 foreign companies (operation, pharmaceutical packaging business, and development in China);
• 16 Chinese companies (operation, pharmaceutical packaging business, and forecast)

Table of Contents:
1 Overview
2 Chinese Pharmaceutical Packaging Industry
3 Foreign Companies
4 Chinese Companies

About Us:
ReportsnReports.com is your single source for all market research needs. Our database includes 500,000+ market research reports from over 95 leading global publishers & in-depth market research studies of over 5000 micro markets. With comprehensive information about the publishers and the industries for which they publish market research reports, we help you in your purchase decision by mapping your information needs with our huge collection of reports.

+ 1 888 391 5441
sales@reportsandreports.com

This release was published on openPR.